EBV-associated post-transplant lymphoproliferative disorder after umbilical cord blood transplantation in adults with hematological diseases. (Q42251934)

From Wikidata

Jump to navigation Jump to search

scientific article published on 2 December 2013

Language	Label	Description	Also known as
English	EBV-associated post-transplant lymphoproliferative disorder after umbilical cord blood transplantation in adults with hematological diseases.	scientific article published on 2 December 2013

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24292521%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

EBV-associated post-transplant lymphoproliferative disorder after umbilical cord blood transplantation in adults with hematological diseases (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24292521%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

post-transplant lymphoproliferative disorder

0 references

José Luis López-Hontangas

15

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24292521%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

author name string

J Sanz

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24292521%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

M Arango

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24292521%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

L Senent

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24292521%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

I Jarque

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24292521%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

P Montesinos

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24292521%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

A Sempere

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24292521%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

I Lorenzo

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24292521%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

G Martín

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24292521%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

F Moscardó

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24292521%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

E Mayordomo

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24292521%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

M Salavert

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24292521%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

C Cañigral

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24292521%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

B Boluda

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24292521%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

C Salazar

14

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24292521%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

M A Sanz

16

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24292521%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

G F Sanz

17

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24292521%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

language of work or name

0 references

publication date

2 December 2013

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24292521%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Bone Marrow Transplantation

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24292521%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

49

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24292521%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24292521%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

397-402

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24292521%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Marked increased risk of Epstein-Barr virus-related complications with the addition of antithymocyte globulin to a nonmyeloablative conditioning prior to unrelated umbilical cord blood transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.190

21 January 2018

Cord blood transplantation from unrelated donors in adults with high-risk acute myeloid leukemia.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.190

21 January 2018

Incidence, risk factors, and outcome of cytomegalovirus infection and disease in patients receiving prophylaxis with oral valganciclovir or intravenous ganciclovir after umbilical cord blood transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.190

21 January 2018

Management of HSV, VZV and EBV infections in patients with hematological malignancies and after SCT: guidelines from the Second European Conference on Infections in Leukemia

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.190

21 January 2018

Impact of hematopoietic chimerism at day +14 on engraftment after unrelated donor umbilical cord blood transplantation for hematologic malignancies

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.190

21 January 2018

Estimation of failure probabilities in the presence of competing risks: new representations of old estimators

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.190

21 January 2018

A Proportional Hazards Model for the Subdistribution of a Competing Risk

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.190

21 January 2018

Increased incidence of EBV-related disease following paediatric stem cell transplantation with reduced-intensity conditioning

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.190

21 January 2018

Posttransplant lymphoproliferative disorder: significance of central nervous system involvement

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.190

21 January 2018

Fatal central nervous system lesions emerging during anti-CD20 monoclonal antibody therapy (Rituximab) for a post transplantation Epstein Barr virus-linked lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.190

21 January 2018

Risk factors for lymphoproliferative disorders after allogeneic hematopoietic cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.190

21 January 2018

Human immunodeficiency virus (HIV)-negative plasmablastic lymphoma: a single institutional experience and literature review

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.190

21 January 2018

Clinicopathologic spectrum and EBV status of post-transplant lymphoproliferative disorders after allogeneic hematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.190

21 January 2018

Donor-derived second hematologic malignancies after cord blood transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.190

21 January 2018

How I treat EBV lymphoproliferation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.190

21 January 2018

Post transplant lymphoproliferative disorders: risk, classification, and therapeutic recommendations.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.190

21 January 2018

Long-term outcome of EBV-specific T-cell infusions to prevent or treat EBV-related lymphoproliferative disease in transplant recipients

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.190

21 January 2018

Successful treatment of EBV-associated posttransplantation lymphoma after cord blood transplantation using third-party EBV-specific cytotoxic T lymphocytes.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.190

21 January 2018

Allogeneic haematopoietic stem-cell transplantation with reduced intensity conditioning for advanced stage Hodgkin's lymphoma in Sweden: high incidence of post transplant lymphoproliferative disorder

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.190

21 January 2018

Persistence of the Epstein-Barr virus and the origins of associated lymphomas

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.190

21 January 2018

Plasma Epstein-Barr virus (EBV) DNA is a biomarker for EBV-positive Hodgkin's lymphoma.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.190

21 January 2018

Single-unit umbilical cord blood transplantation from unrelated donors in patients with hematological malignancy using busulfan, thiotepa, fludarabine and ATG as myeloablative conditioning regimen

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.190

21 January 2018

Incidence and risk factors of EBV reactivation after unrelated cord blood transplantation: a Eurocord and Société Française de Greffe de Moelle-Therapie Cellulaire collaborative study

1 reference

https://pubmed.ncbi.nlm.nih.gov/24292521

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Risk of lymphoproliferative disorders after bone marrow transplantation: a multi-institutional study

1 reference

https://pubmed.ncbi.nlm.nih.gov/24292521

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lymphoproliferative disorders following allogeneic bone marrow transplantation: the Vancouver experience

1 reference

https://pubmed.ncbi.nlm.nih.gov/24292521

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Infectious complications following unrelated cord blood transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/24292521

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Central nervous system lymphomas in organ allograft recipients

1 reference

https://pubmed.ncbi.nlm.nih.gov/24292521

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42251934&oldid=2205167144"